- Home
- » Tags
- » Hit to lead
Top View
- Simulating the Drug Discovery Pipeline: a Monte Carlo Approach Melvin J Yu
- Hit and Lead Generation: Beyond High-Throughput Screening
- Synthesis of Six-Membered Rings and Inhibitors of Protein Kinases
- The Screening Compound Collection: a Key Asset for Drug Discovery
- Chapter 10 | Lead Discovery
- Developing Antagonists for the Met-HGF/SF Protein–Protein Interaction Using a Fragment- Based Approach Anja Winter1, Anna G
- (12) United States Patent (10) Patent No.: US 8,691,849 B2 Cid-Nunez Et Al
- Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures S
- MEDICINAL CHEMISTRY: from HIT to LEAD CCTS Drug Discovery Seminar Series May 4, 2018 Corinne E
- Drug Discovery and Development Drug Discovery and Development
- The Pharmacologist September
- Phosphorylation State-Dependent High Throughput Screening of the C-Met Kinase
- Hit-To-Lead Optimization of Small Molecules for Neglected Tropical Disease Therapeutics
- MEDICINAL CHEMISTRY: from HIT to LEAD Alabama Drug Discovery Alliance Lecture Series March 14, 2017 Corinne E
- 'Lead' to 'Candidate' Optimisation Using Multi-Parametric Principles
- Part One Screening, Bioinformatics, Chemoinformatics, and Drug Design
- Computational Approaches in Molecular and Systems Pharmacology
- AACR Cancer Progress Report 2016
- Epigenetic Assays for Chemical Biology and Drug Discovery Sheraz Gul
- Identification of Potential Drug Targets in Kinetic Networks Described By
- Perspectives
- Inhibition of Oncogenic Kinases: an in Vitro Validated Computational Approach Identified Potential Multi- Target Anticancer Compounds
- Freundlich CV
- Universidad Complutense De Madrid
- Chemistry-Driven Hit-To-Lead Optimization Guided by Structure-Based Approaches Laurent Hoffer, Christophe Muller, Philippe Roche, Xavier Morelli
- Aacr Cancer Progress Report
- Freundlich CV
- Overview of Services
- Perspectives
- Mechanistic Enzymology in Drug Discovery: a Fresh Perspective
- Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCR
- Scientific Program
- New Carbapenemase Inhibitors: Clearing the Way for the -Lactams
- Cheminformatic Characterization of Natural Antimicrobial Products for the Development of New Lead Compounds
- MEDICINAL CHEMISTRY: from HIT to LEAD Alabama Drug Discovery Alliance Lecture Series 2015